drugset / Trial / NCT04950647
Efficacy and Safety of Nitrazine in the Treatment of ALS
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the trend of safety and effectiveness of Nitroketazine tablets for ALS patients, and to explore the best effective dose.
Timeline
- Start
- 2020-07-01
- Primary completion
- 2022-07-31
- Completion
- 2022-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nitroketazine | Unknown | 600 mg | Oral |
| Subject | Nitroketazine | Unknown | 1200 mg | Oral |